Experienced in Defective Apolipoprotein B-100

Dr. Steven K. Krueger

Cardiology
Chi Health Clinic Specialty LLC
1579 Midland St, 
Syracuse, NE 
Accepting New Patients
Experienced in Defective Apolipoprotein B-100
Chi Health Clinic Specialty LLC
1579 Midland St, 
Syracuse, NE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Krueger is a Cardiologist in Syracuse, Nebraska. Dr. Krueger is rated as an Experienced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Heart Failure, Coronary Heart Disease, Atherosclerosis, and Angina. Dr. Krueger is currently accepting new patients.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Cardiology
Licenses
Internal Medicine in NE
Hospital Affiliations
Chi Health Nebraska Heart
York General Health Care Services
Syracuse Area Health
Chi Health St. Mary's
Beatrice Community Hospital & Health Center, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

CHI HEALTH CLINIC SPECIALTY LLC
1579 Midland St, Syracuse, NE 68446
Other Locations
CHI HEALTH CLINIC SPECIALTY LLC
7440 S 91st St, Nebraska Heart Institute, Lincoln, NE 68526
CHI HEALTH CLINIC SPECIALTY LLC
2620 W Faidley Ave, St. Francis Medical Center, Grand Island, NE 68803
CHI HEALTH CLINIC SPECIALTY LLC
2222 N Lincoln Ave, York General Hospital, York, NE 68467
CHI HEALTH CLINIC SPECIALTY LLC
8207 Northwoods Dr, 100 Nebraska Endocrinology, Lincoln, NE 68505
CHI HEALTH CLINIC SPECIALTY LLC
1301 Grundman Blvd, Nebraska City, NE 68410
CHI HEALTH CLINIC SPECIALTY LLC
4800 Hospital Pkwy, Beatrice, NE 68310

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Active_not_recruiting
Publish Date: July 09, 2025
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Evaluation of the Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%: FIX-HF-5C
Enrollment Status: Completed
Publish Date: September 17, 2021
Intervention Type: Device, Other
Study Phase: Not Applicable
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Sensible Medical Innovations (Noninvasive) Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients- a Randomized Controlled Study
Enrollment Status: Terminated
Publish Date: December 29, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 2 Less Clinical Trials

9 Total Publications

Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.
Bucindolol Decreases Atrial Fibrillation Burden in Patients With Heart Failure and the ADRB1 Arg389Arg Genotype.
Journal: Circulation. Arrhythmia and electrophysiology
Published: July 16, 2021
Similar Doctors
Advanced in Defective Apolipoprotein B-100
Dr. Randal S. Cassling
Cardiology
Advanced in Defective Apolipoprotein B-100
Dr. Randal S. Cassling
Cardiology

Physicians Clinic Inc

1120 N 103rd Plz, 
Omaha, NE 
 (42.1 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Randal Cassling is a Cardiologist in Omaha, Nebraska. Dr. Cassling is rated as an Advanced provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Cor Pulmonale, Coronary Heart Disease, Atherosclerosis, and Angina. Dr. Cassling is currently accepting new patients.

Advanced in Defective Apolipoprotein B-100
Dr. Chad E. Travers
Cardiology
Advanced in Defective Apolipoprotein B-100
Dr. Chad E. Travers
Cardiology

Integrated Cardiology Group LLC

1600 S 48th St, 
Lincoln, NE 
 (25.9 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Chad Travers is a Cardiologist in Lincoln, Nebraska. Dr. Travers is rated as a Distinguished provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Atrial Fibrillation, Coronary Heart Disease, Angina, Pacemaker Implantation, and Heart Bypass Surgery. Dr. Travers is currently accepting new patients.

Experienced in Defective Apolipoprotein B-100
Dr. Michael M. Dehning
Cardiology
Experienced in Defective Apolipoprotein B-100
Dr. Michael M. Dehning
Cardiology

Physicians Clinic Inc

1 Edmundson Pl, 306 Methodist Physicians C, 
Council Bluffs, IA 
 (45.3 miles away)
712-396-7787
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Dehning is a Cardiologist in Council Bluffs, Iowa. Dr. Dehning is rated as a Distinguished provider by MediFind in the treatment of Defective Apolipoprotein B-100. His top areas of expertise are Coronary Heart Disease, Angina, Atherosclerosis, Heart Bypass Surgery, and Pacemaker Implantation. Dr. Dehning is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Krueger's expertise for a condition
ConditionClose
    View All 7 Distinguished Conditions
    View All 30 Advanced Conditions
    View All 65 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile